002932 *ST明德
午间休市 11-18 11:30:00
资讯
新帖
简况
股市必读:*ST明德新发布《北京大成(武汉)律师事务所关于武汉明德生物科技股份有限公司2026年第二次临时股东会的法律意见书》
证券之星 · 03:55
股市必读:*ST明德新发布《北京大成(武汉)律师事务所关于武汉明德生物科技股份有限公司2026年第二次临时股东会的法律意见书》
*ST明德(002932)披露2026年第二次临时股东会决议公告,11月17日股价上涨0.07%
证券之星 · 11-17 22:38
*ST明德(002932)披露2026年第二次临时股东会决议公告,11月17日股价上涨0.07%
*ST明德:公司将综合公司发展战略、市场情况、股东建议等因素统筹研判后续回购计划与股份处置方式
证券之星 · 11-12
*ST明德:公司将综合公司发展战略、市场情况、股东建议等因素统筹研判后续回购计划与股份处置方式
*ST明德:公司本次涉税事项是依据相关税收法律法规的要求,对涉税事项进行的调整
证券之星 · 11-12
*ST明德:公司本次涉税事项是依据相关税收法律法规的要求,对涉税事项进行的调整
*ST明德:相关合作事项未达到法定披露标准
证券之星 · 11-12
*ST明德:相关合作事项未达到法定披露标准
*ST明德:部分海外本地化据点已落地运营
证券之星 · 11-12
*ST明德:部分海外本地化据点已落地运营
股市必读:*ST明德新发布《关于重大资产购买之标的资产过渡期损益情况的公告》
证券之星 · 11-11
股市必读:*ST明德新发布《关于重大资产购买之标的资产过渡期损益情况的公告》
*ST明德:本次涉税事项不涉及行政处罚
证券之星 · 11-10
*ST明德:本次涉税事项不涉及行政处罚
*ST明德:已推出三联检、六联检、合胞病毒检测试剂盒、腺病毒检测试剂盒等多款呼吸道检测产品
证券之星 · 11-10
*ST明德:已推出三联检、六联检、合胞病毒检测试剂盒、腺病毒检测试剂盒等多款呼吸道检测产品
*ST明德:目前公司正根据整体战略规划,对包括品牌展示在内的资源配置进行统筹优化
证券之星 · 11-10
*ST明德:目前公司正根据整体战略规划,对包括品牌展示在内的资源配置进行统筹优化
*ST明德:非同一控制下企业合并将标的公司购买日至报告期末的收入并入上市公司合并利润表
证券之星 · 11-10
*ST明德:非同一控制下企业合并将标的公司购买日至报告期末的收入并入上市公司合并利润表
*ST明德:公司各项业务正常开展
证券之星 · 11-10
*ST明德:公司各项业务正常开展
*ST明德:截止2026年10月30日,公司股东总户数为13,939户
证券之星 · 11-10
*ST明德:截止2026年10月30日,公司股东总户数为13,939户
*ST明德(002932)披露重大资产购买之标的资产过渡期损益情况公告,11月09日股价上涨0.07%
证券之星 · 11-09
*ST明德(002932)披露重大资产购买之标的资产过渡期损益情况公告,11月09日股价上涨0.07%
*ST明德(002932)披露2026年三季度报告,11月02日股价上涨1.48%
证券之星 · 11-02
*ST明德(002932)披露2026年三季度报告,11月02日股价上涨1.48%
*ST明德(002932)2026年三季报简析:增收不增利,存货明显上升
证券之星 · 11-01
*ST明德(002932)2026年三季报简析:增收不增利,存货明显上升
*ST明德(002932)9月30日股东户数1.42万户,较上期减少4.38%
证券之星 · 10-31
*ST明德(002932)9月30日股东户数1.42万户,较上期减少4.38%
图解*ST明德三季报:第三季度单季净利润同比下降1289.07%
证券之星 · 10-31
图解*ST明德三季报:第三季度单季净利润同比下降1289.07%
股市必读:*ST明德新发布《关于完成工商变更登记并换发营业执照的公告》
证券之星 · 10-26
股市必读:*ST明德新发布《关于完成工商变更登记并换发营业执照的公告》
*ST明德:公司产品管线中暂无梅毒螺旋体抗体检测试剂
证券之星 · 09-23
*ST明德:公司产品管线中暂无梅毒螺旋体抗体检测试剂
加载更多
公司概况
公司名称:
武汉明德生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2018-07-10
主营业务:
武汉明德生物科技股份有限公司的主营业务是体外诊断试剂和诊断仪器的研发、生产、销售和服务。公司的主要产品是体外诊断试剂、诊断仪器。
发行价格:
20.45
{"stockData":{"symbol":"002932","market":"SZ","secType":"STK","nameCN":"*ST明德","latestPrice":14.24,"timestamp":1794974382000,"preClose":14.3,"halted":0,"volume":546347,"delay":0,"changeRate":-0.0042,"floatShares":156000000,"shares":233000000,"eps":-0.2751,"marketStatus":"午间休市","change":-0.06,"latestTime":"11-18 11:30:00","open":14.21,"high":14.3,"low":14.17,"amount":7775100,"amplitude":0.0091,"askPrice":14.25,"askSize":32,"bidPrice":14.21,"bidSize":54,"shortable":0,"etf":0,"ttmEps":-0.2751,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794978000000},"marketStatusCode":3,"adr":0,"adjPreClose":14.3,"symbolType":"stock","openAndCloseTimeList":[[1794965400000,1794972600000],[1794978000000,1794985200000]],"highLimit":15.02,"lowLimit":13.59,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":232520957,"isCdr":false,"pbRate":0.62,"roa":"--","roe":"--","epsLYR":-0.07,"committee":0.641256,"marketValue":3311000000,"turnoverRate":0.0035,"status":1,"floatMarketCap":2223000000},"requestUrl":"/m/hq/s/002932","defaultTab":"news","newsList":[{"id":"2684935389","title":"股市必读:*ST明德新发布《北京大成(武汉)律师事务所关于武汉明德生物科技股份有限公司2026年第二次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2684935389","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684935389?lang=zh_cn&edition=full","pubTime":"2026-11-18 03:55","pubTimestamp":1794945310,"startTime":"0","endTime":"0","summary":"2026年第二次临时股东会决议公告武汉明德生物科技股份有限公司于2026年11月17日召开2026年第二次临时股东会,会议由董事会召集,董事长陈莉莉主持,采用现场与网络投票结合方式召开。会议审议通过了关于拟续聘会计师事务所的议案,表决结果为同意105,354,097股,占出席会议有效表决权的99.8522%,议案获得通过。北京大成(武汉)律师事务所对本次会议出具法律意见,认为会议召集、召开程序及表决结果合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111800003279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2684989716","title":"*ST明德(002932)披露2026年第二次临时股东会决议公告,11月17日股价上涨0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2684989716","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2684989716?lang=zh_cn&edition=full","pubTime":"2026-11-17 22:38","pubTimestamp":1794926307,"startTime":"0","endTime":"0","summary":"截至2026年11月17日收盘,*ST明德报收于14.3元,较前一交易日上涨0.07%,最新总市值为33.25亿元。近日,武汉明德生物科技股份有限公司发布《2026年第二次临时股东会决议公告》。公告显示,公司于2026年11月17日召开2026年第二次临时股东会,会议由董事会召集,董事长陈莉莉主持,采用现场与网络投票结合方式召开。出席会议股东共74人,代表股份105,510,078股,占公司有表决权股份总数的50.2311%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111700043548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682259655","title":"*ST明德:公司将综合公司发展战略、市场情况、股东建议等因素统筹研判后续回购计划与股份处置方式","url":"https://stock-news.laohu8.com/highlight/detail?id=2682259655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682259655?lang=zh_cn&edition=full","pubTime":"2026-11-12 20:48","pubTimestamp":1794487692,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德(002932)11月11日在投资者关系平台上答复投资者关心的问题。投资者提问:公司已经两次回购,回购股份达到10%的上限!为什么不学习其他公司回购后注销?也可以新增第三次回购用于注销,这样也符合相关法律规定。请公司关注股价已严重低于净资产,这个事实!*ST明德回复:尊敬的投资者您好,公司已按回购方案执行了回购,并披露了回购完成相关情况。公司将综合公司发展战略、市场情况、股东建议等因素统筹研判后续回购计划与股份处置方式,如有变动将及时履行审议披露程序。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200039069.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682374595","title":"*ST明德:公司本次涉税事项是依据相关税收法律法规的要求,对涉税事项进行的调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2682374595","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682374595?lang=zh_cn&edition=full","pubTime":"2026-11-12 11:37","pubTimestamp":1794454636,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德(002932)11月11日在投资者关系平台上答复投资者关心的问题。投资者提问:公司因为什么事项补税是属于商业秘密吗?如果不是商业秘密,为什么不直接告知投资者具体的补税项目信息?公司股价长期不振是有原因的,公司这种对工作方式不可取。*ST明德回复:尊敬的投资者您好,公司本次涉税事项是依据相关税收法律法规的要求,对涉税事项进行的调整,该事项不涉及行政处罚,不涉及前期财务数据追溯调整。具体情形请以公司公告为准。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200014985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682537441","title":"*ST明德:相关合作事项未达到法定披露标准","url":"https://stock-news.laohu8.com/highlight/detail?id=2682537441","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682537441?lang=zh_cn&edition=full","pubTime":"2026-11-12 11:37","pubTimestamp":1794454629,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德(002932)11月11日在投资者关系平台上答复投资者关心的问题。投资者提问:明德生物近期已先后与杭州博岳生物技术有限公司、珠海丽珠试剂股份有限公司签署正式战略合作协议,但均无公告。请问像这些能够反映和传递企业及经营积极向好的信息,为啥不公布呢?*ST明德回复:尊敬的投资者您好,公司严格遵守信息披露规定,相关合作事项未达到法定披露标准。公司始终重视投资者关系管理,在合规前提下通过多种渠道传递经营信息,重大事项将依规及时披露。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200014977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682537107","title":"*ST明德:部分海外本地化据点已落地运营","url":"https://stock-news.laohu8.com/highlight/detail?id=2682537107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682537107?lang=zh_cn&edition=full","pubTime":"2026-11-12 11:37","pubTimestamp":1794454626,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德(002932)11月11日在投资者关系平台上答复投资者关心的问题。投资者提问:公司宣传提到具有全球100多个国际和地区的销售渠道,请问,这个是公司产品已经在销售的渠道还是未来将要拓展的渠道数量的目标?未来公司将如何利用好这些优势资源?*ST明德回复:尊敬的投资者您好,公司近年来积极开拓海外市场,持续开展产品出口认证、场推广及代理商体系建设,部分海外本地化据点已落地运营,为属地客户提供产品与技术服务。海外业务拓展存在不确定性,详细经营数据请查阅公司定期报告。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200014969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682553343","title":"股市必读:*ST明德新发布《关于重大资产购买之标的资产过渡期损益情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2682553343","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682553343?lang=zh_cn&edition=full","pubTime":"2026-11-11 04:08","pubTimestamp":1794341294,"startTime":"0","endTime":"0","summary":"公司公告汇总关于重大资产购买之标的资产过渡期损益情况的公告武汉明德生物科技股份有限公司以支付现金方式收购蓝帆医疗持有的武汉必凯尔救助用品有限公司100%股权,标的资产已过户完成;立信会计师事务所审计确认过渡期未发生亏损,不涉及蓝帆医疗现金补偿,过渡期收益由公司享有。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111100008173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682528153","title":"*ST明德:本次涉税事项不涉及行政处罚","url":"https://stock-news.laohu8.com/highlight/detail?id=2682528153","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682528153?lang=zh_cn&edition=full","pubTime":"2026-11-10 11:38","pubTimestamp":1794281904,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德(002932)11月09日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,关注到公司公告补缴税款及滞纳金合计3746万元,请问本次涉税事项是公司内部自查发现,还是收到税务机关提示/风险告知后进行补缴?*ST明德回复:尊敬的投资者您好,公司本次涉税事项是依据相关税收法律法规的要求,对涉税事项进行的调整,该事项不涉及行政处罚,不涉及前期财务数据追溯调整。具体情形请以公司公告为准。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000015032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682354003","title":"*ST明德:已推出三联检、六联检、合胞病毒检测试剂盒、腺病毒检测试剂盒等多款呼吸道检测产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2682354003","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682354003?lang=zh_cn&edition=full","pubTime":"2026-11-10 11:38","pubTimestamp":1794281904,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德(002932)11月09日在投资者关系平台上答复投资者关心的问题。投资者提问:近期,中疾控最新监测数据显示全国流感活动水平上升,南方省份流感样病例阳性率高达24.9%。公司有相关的检测产品吗?*ST明德回复:尊敬的投资者您好,公司已推出三联检、六联检、合胞病毒检测试剂盒、腺病毒检测试剂盒等多款呼吸道检测产品,公司将持续优化产品与服务。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000015031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682528093","title":"*ST明德:目前公司正根据整体战略规划,对包括品牌展示在内的资源配置进行统筹优化","url":"https://stock-news.laohu8.com/highlight/detail?id=2682528093","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682528093?lang=zh_cn&edition=full","pubTime":"2026-11-10 11:38","pubTimestamp":1794281889,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德(002932)11月09日在投资者关系平台上答复投资者关心的问题。投资者提问:公司官网含英文版本网站至今未对今年新并购的业务做介绍,是工作不作为还是什么原因?还是一直所谓的在整合?请介绍,谢谢。*ST明德回复:尊敬的投资者您好,目前公司正根据整体战略规划,对包括品牌展示在内的资源配置进行统筹优化,后续将依据整合进度适时完善产品展示体系。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000015027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682735233","title":"*ST明德:非同一控制下企业合并将标的公司购买日至报告期末的收入并入上市公司合并利润表","url":"https://stock-news.laohu8.com/highlight/detail?id=2682735233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682735233?lang=zh_cn&edition=full","pubTime":"2026-11-10 11:38","pubTimestamp":1794281888,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德(002932)11月09日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,作为中小股东,咨询收购必凯尔的并表问题:收购必凯尔100%股权的购买日是2026年8月14日,因属非同一控制并购,请问明德2026年报中,必凯尔营收是仅合并8月14日后的部分,还是合并全年的?*ST明德回复:尊敬的投资者您好,根据企业会计准则相关规定,非同一控制下企业合并,将标的公司购买日至报告期末的收入并入上市公司合并利润表。公司及子公司业绩信息请以公司披露的定期报告及相关公告为准。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000015024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682540053","title":"*ST明德:公司各项业务正常开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2682540053","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682540053?lang=zh_cn&edition=full","pubTime":"2026-11-10 11:38","pubTimestamp":1794281881,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德(002932)11月09日在投资者关系平台上答复投资者关心的问题。投资者提问:公司当前经营基本面如何?*ST明德回复:尊敬的投资者您好,公司经营情况请以公司在指定信息披露媒体发布的相关公告内容为准。公司各项业务正常开展,管理层将持续做好经营管理,积极维护公司及全体股东利益。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000015018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682352841","title":"*ST明德:截止2026年10月30日,公司股东总户数为13,939户","url":"https://stock-news.laohu8.com/highlight/detail?id=2682352841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682352841?lang=zh_cn&edition=full","pubTime":"2026-11-10 11:37","pubTimestamp":1794281865,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德(002932)11月09日在投资者关系平台上答复投资者关心的问题。投资者提问:公司最近股东人数情况如何,谢谢*ST明德回复:尊敬的投资者您好,截止2026年10月30日,公司股东总户数为13,939户。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000015001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682037384","title":"*ST明德(002932)披露重大资产购买之标的资产过渡期损益情况公告,11月09日股价上涨0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682037384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682037384?lang=zh_cn&edition=full","pubTime":"2026-11-09 22:54","pubTimestamp":1794236047,"startTime":"0","endTime":"0","summary":"截至2026年11月9日收盘,*ST明德报收于14.53元,较前一交易日上涨0.07%,最新总市值为33.79亿元。近日,*ST明德披露《关于重大资产购买之标的资产过渡期损益情况的公告》。公告显示,公司以支付现金方式收购蓝帆医疗持有的武汉必凯尔救助用品有限公司100%股权,标的资产已过户完成。公司聘请立信会计师事务所对必凯尔过渡期损益情况进行审计,结果显示过渡期间未发生亏损,不涉及蓝帆医疗现金补偿,过渡期内产生的收益由公司享有。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900024741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680849751","title":"*ST明德(002932)披露2026年三季度报告,11月02日股价上涨1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680849751","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680849751?lang=zh_cn&edition=full","pubTime":"2026-11-02 19:43","pubTimestamp":1793619823,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘,*ST明德报收于14.43元,较前一交易日上涨1.48%,最新总市值为33.55亿元。该股当日开盘14.31元,最高14.45元,最低14.23元,成交额达764.18万元,换手率为0.34%。公司近日披露《2026年三季度报告》。公告显示,2026年第三季度营业收入139,611,753.05元,同比增长59.52%;归属于上市公司股东的净利润-12,106,916.58元,同比减少1,289.07%。年初至报告期末营业收入281,042,478.40元,同比增长23.91%;归属于上市公司股东的净利润-33,974,541.33元,同比减少351.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200030371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680725502","title":"*ST明德(002932)2026年三季报简析:增收不增利,存货明显上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2680725502","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680725502?lang=zh_cn&edition=full","pubTime":"2026-11-01 06:33","pubTimestamp":1793485986,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期*ST明德发布2026年三季报。截至本报告期末,公司营业总收入2.81亿元,同比上升23.91%,归母净利润-3397.45万元,同比下降351.37%。本报告期*ST明德存货明显上升,存货同比增幅达51.44%。本次财报公布的各项数据指标表现一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110100001724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679028278","title":"*ST明德(002932)9月30日股东户数1.42万户,较上期减少4.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679028278","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679028278?lang=zh_cn&edition=full","pubTime":"2026-10-31 17:19","pubTimestamp":1793438384,"startTime":"0","endTime":"0","summary":"证券之星消息,近日*ST明德披露,截至2026年9月30日公司股东户数为1.42万户,较7月31日减少650.0户,减幅为4.38%。在医疗器械行业个股中,*ST明德股东户数低于行业平均水平,截至9月30日,医疗器械行业平均股东户数为2.11万户。从股价来看,2026年7月31日至2026年9月30日,*ST明德区间涨幅为4.93%,在此期间股东户数减少650.0户,减幅为4.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100033495.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679410582","title":"图解*ST明德三季报:第三季度单季净利润同比下降1289.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679410582","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679410582?lang=zh_cn&edition=full","pubTime":"2026-10-31 01:58","pubTimestamp":1793383134,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德2026年三季报显示,前三季度公司主营收入2.81亿元,同比上升23.91%;归母净利润-3397.45万元,同比下降351.37%;扣非净利润-7468.09万元,同比下降17.92%;其中2026年第三季度,公司单季度主营收入1.4亿元,同比上升59.52%;单季度归母净利润-1210.69万元,同比下降1289.07%;单季度扣非净利润-2589.56万元,同比上升6.54%;负债率6.3%,投资收益3016.12万元,财务费用622.03万元,毛利率40.1%。财报数据概要请见下图:本文数据来源于*ST明德2026年三季报,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100003781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678132665","title":"股市必读:*ST明德新发布《关于完成工商变更登记并换发营业执照的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678132665","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678132665?lang=zh_cn&edition=full","pubTime":"2026-10-26 08:10","pubTimestamp":1792973431,"startTime":"0","endTime":"0","summary":"公司已完成工商变更登记及《公司章程》备案手续,并取得由武汉市市场监督管理局核发的新营业执照。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600002233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669913175","title":"*ST明德:公司产品管线中暂无梅毒螺旋体抗体检测试剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2669913175","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669913175?lang=zh_cn&edition=full","pubTime":"2026-09-23 08:48","pubTimestamp":1790124489,"startTime":"0","endTime":"0","summary":"证券之星消息,*ST明德(002932)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问:明德生物的荧光免疫POCT仪器,搭配明德配套的梅毒螺旋体抗体检测试剂卡,可以检测血液中的梅毒螺旋体抗体,属于快速筛查。请问是否具有该产品?*ST明德回复:尊敬的投资者您好,公司产品管线中暂无梅毒螺旋体抗体检测试剂。感谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300008393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002932"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794974441661,"stockEarnings":[{"period":"1week","weight":-0.0172},{"period":"1month","weight":-0.0172},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.1243},{"period":"1year","weight":-0.28},{"period":"ytd","weight":-0.2544}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":-0.0354},{"period":"3month","weight":-0.0796},{"period":"6month","weight":-0.1208},{"period":"1year","weight":-0.0975},{"period":"ytd","weight":-0.0968}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"武汉明德生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"13939人(较上一季度减少1.78%)","perCapita":"11198股","listingDate":"2018-07-10","address":"湖北省武汉市江夏区东湖新技术开发区九龙中路77号武汉明德生物科技产业园(一期)(全部自用)1栋1单元1层1号C区","registeredCapital":"23252万元","survey":" 武汉明德生物科技股份有限公司的主营业务是体外诊断试剂和诊断仪器的研发、生产、销售和服务。公司的主要产品是体外诊断试剂、诊断仪器。","listedPrice":20.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"*ST明德(002932)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供*ST明德(002932)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"*ST明德,002932,*ST明德股票,*ST明德股票老虎,*ST明德股票老虎国际,*ST明德行情,*ST明德股票行情,*ST明德股价,*ST明德股市,*ST明德股票价格,*ST明德股票交易,*ST明德股票购买,*ST明德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"*ST明德(002932)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供*ST明德(002932)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}